Ozon Pharmaceuticals has started collecting applications for participation in the SPO, within the framework of which it plans to place 55-82 million shares, or 5-7.5% of the authorized capital. Collection of applications will last until June 19, 2025. SPO price will be determined based on the results of the order book, but is not expected to exceed ₽48 per share. It is also not expected to exceed the closing price of the main trading session on the Moscow Exchange on June 19, 2025.